论文信息 - Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y 12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study - 字舞流文

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y 12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study

L. Been | D. Angiolillo | F. Rollini | L. Jennings | M. Galli | Andres M Pineda | S. Suryadevara | D. Soffer | L. Ortega‐Paz | Xuan Zhou | Ghussan Ghanem | Awss Shalhoub | Francesco Franchi | Andrea Rivas | Martin M. Zenni | Tiffany Ossi